Top Key Companies for Celiac Disease Diagnostics Market: Thermo Fisher Scientific Inc., PRIMA Lab SA, Glutenostics, Inc., NanoRepro AG., Targeted Genomics, YORKTEST Laboratories, Biohit Oyj, Labsystems Diagnostics Oy, RxHome Test, Biomerica, AESKU.GROUP GmbH, LaCAR MDx Technologies, J. Mitra & Co.Pvt.Ltd., lmaware, Vitrosens Biotechnology.
Global Celiac Disease Diagnostics Market Size was estimated at USD 6040.3 million in 2022 and is projected to reach USD 8519.9 million by 2028, exhibiting a CAGR of 5.9% during the forecast period.
Global Celiac Disease Diagnostics Market Overview And Scope:
The Global Celiac Disease Diagnostics Market Report 2026 provides comprehensive analysis of market development components, patterns, flows, and sizes. This research study of Celiac Disease Diagnostics utilized both primary and secondary data sources to calculate present and past market values to forecast potential market management for the forecast period between 2026 and 2035. It includes the study of a wide range of industry parameters, including government policies, market environments, competitive landscape, historical data, current market trends, technological innovations, upcoming technologies, and technological progress within related industries. Additionally, the report provides an in-depth analysis of the value chain and supply chain to demonstrate how value is added at every stage in the product lifecycle. The study incorporates market dynamics such as drivers, restraints/challenges, trends, and their impact on the market.
This Market Research Report provides a comprehensive analysis of the global Celiac Disease Diagnostics Market and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Celiac Disease Diagnostics portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Celiac Disease Diagnostics market.
Global Celiac Disease Diagnostics Market Segmentation
By Type, Celiac Disease Diagnostics market has been segmented into:
Serology Rapid Test Kit
Gene Rapid Detection Kit
By Application, Celiac Disease Diagnostics market has been segmented into:
Hospital
Diagnostic Laboratory
Specialty Clinic
Other
Regional Analysis of Celiac Disease Diagnostics Market:
North America (U.S., Canada, Mexico)
Eastern Europe (Bulgaria, The Czech Republic, Hungary, Poland, Romania, Rest of Eastern Europe)
Western Europe (Germany, UK, France, Netherlands, Italy, Russia, Spain, Rest of Western Europe)
Asia-Pacific (China, India, Japan, Singapore, Australia, New Zealand, Rest of APAC)
South America (Brazil, Argentina, Rest of SA)
Middle East & Africa (Turkey, Bahrain, Kuwait, Saudi Arabia, Qatar, UAE, Israel, South Africa)
Competitive Landscape of Celiac Disease Diagnostics Market:
Competitive analysis is the study of strength and weakness, market investment, market share, market sales volume, market trends of major players in the market.The Celiac Disease Diagnostics market study focused on including all the primary level, secondary level and tertiary level competitors in the report.The data generated by conducting the primary and secondary research. The report covers detail analysis of driver, constraints and scope for new players entering the Celiac Disease Diagnostics market.
Top Key Companies Covered in Celiac Disease Diagnostics market are:
Thermo Fisher Scientific Inc.
PRIMA Lab SA
Glutenostics
Inc.
NanoRepro AG.
Targeted Genomics
YORKTEST Laboratories
Biohit Oyj
Labsystems Diagnostics Oy
RxHome Test
Biomerica
AESKU.GROUP GmbH
LaCAR MDx Technologies
J. Mitra & Co.Pvt.Ltd.
lmaware
Vitrosens Biotechnology
Chapter 1: Introduction
1.1 Research Objectives
1.2 Research Methodology
1.3 Research Process
1.4 Scope and Coverage
1.4.1 Market Definition
1.4.2 Key Questions Answered
1.5 Market Segmentation
Chapter 2:Executive Summary
Chapter 3:Growth Opportunities By Segment
3.1 By Type
3.2 By Application
Chapter 4: Market Landscape
4.1 Porter's Five Forces Analysis
4.1.1 Bargaining Power of Supplier
4.1.2 Threat of New Entrants
4.1.3 Threat of Substitutes
4.1.4 Competitive Rivalry
4.1.5 Bargaining Power Among Buyers
4.2 Industry Value Chain Analysis
4.3 Market Dynamics
4.3.1 Drivers
4.3.2 Restraints
4.3.3 Opportunities
4.5.4 Challenges
4.4 Pestle Analysis
4.5 Technological Roadmap
4.6 Regulatory Landscape
4.7 SWOT Analysis
4.8 Price Trend Analysis
4.9 Patent Analysis
4.10 Analysis of the Impact of Covid-19
4.10.1 Impact on the Overall Market
4.10.2 Impact on the Supply Chain
4.10.3 Impact on the Key Manufacturers
4.10.4 Impact on the Pricing
Chapter 5: Celiac Disease Diagnostics Market by Type
5.1 Celiac Disease Diagnostics Market Overview Snapshot and Growth Engine
5.2 Celiac Disease Diagnostics Market Overview
5.3 Serology Rapid Test Kit
5.3.1 Introduction and Market Overview
5.3.2 Historic and Forecasted Market Size (2026-2035F)
5.3.3 Key Market Trends, Growth Factors and Opportunities
5.3.4 Serology Rapid Test Kit: Geographic Segmentation
5.4 Gene Rapid Detection Kit
5.4.1 Introduction and Market Overview
5.4.2 Historic and Forecasted Market Size (2026-2035F)
5.4.3 Key Market Trends, Growth Factors and Opportunities
5.4.4 Gene Rapid Detection Kit: Geographic Segmentation
Chapter 6: Celiac Disease Diagnostics Market by Application
6.1 Celiac Disease Diagnostics Market Overview Snapshot and Growth Engine
6.2 Celiac Disease Diagnostics Market Overview
6.3 Hospital
6.3.1 Introduction and Market Overview
6.3.2 Historic and Forecasted Market Size (2026-2035F)
6.3.3 Key Market Trends, Growth Factors and Opportunities
6.3.4 Hospital: Geographic Segmentation
6.4 Diagnostic Laboratory
6.4.1 Introduction and Market Overview
6.4.2 Historic and Forecasted Market Size (2026-2035F)
6.4.3 Key Market Trends, Growth Factors and Opportunities
6.4.4 Diagnostic Laboratory: Geographic Segmentation
6.5 Specialty Clinic
6.5.1 Introduction and Market Overview
6.5.2 Historic and Forecasted Market Size (2026-2035F)
6.5.3 Key Market Trends, Growth Factors and Opportunities
6.5.4 Specialty Clinic: Geographic Segmentation
6.6 Other
6.6.1 Introduction and Market Overview
6.6.2 Historic and Forecasted Market Size (2026-2035F)
6.6.3 Key Market Trends, Growth Factors and Opportunities
6.6.4 Other: Geographic Segmentation
Chapter 7: Company Profiles and Competitive Analysis
7.1 Competitive Landscape
7.1.1 Competitive Positioning
7.1.2 Celiac Disease Diagnostics Sales and Market Share By Players
7.1.3 Industry BCG Matrix
7.1.4 Heat Map Analysis
7.1.5 Celiac Disease Diagnostics Industry Concentration Ratio (CR5 and HHI)
7.1.6 Top 5 Celiac Disease Diagnostics Players Market Share
7.1.7 Mergers and Acquisitions
7.1.8 Business Strategies By Top Players
7.2 THERMO FISHER SCIENTIFIC INC.
7.2.1 Company Overview
7.2.2 Key Executives
7.2.3 Company Snapshot
7.2.4 Operating Business Segments
7.2.5 Product Portfolio
7.2.6 Business Performance
7.2.7 Key Strategic Moves and Recent Developments
7.2.8 SWOT Analysis
7.3 PRIMA LAB SA
7.4 GLUTENOSTICS
7.5 INC.
7.6 NANOREPRO AG.
7.7 TARGETED GENOMICS
7.8 YORKTEST LABORATORIES
7.9 BIOHIT OYJ
7.10 LABSYSTEMS DIAGNOSTICS OY
7.11 RXHOME TEST
7.12 BIOMERICA
7.13 AESKU.GROUP GMBH
7.14 LACAR MDX TECHNOLOGIES
7.15 J. MITRA & CO.PVT.LTD.
7.16 LMAWARE
7.17 VITROSENS BIOTECHNOLOGY
Chapter 8: Global Celiac Disease Diagnostics Market Analysis, Insights and Forecast, 2026-2035
8.1 Market Overview
8.2 Historic and Forecasted Market Size By Type
8.2.1 Serology Rapid Test Kit
8.2.2 Gene Rapid Detection Kit
8.3 Historic and Forecasted Market Size By Application
8.3.1 Hospital
8.3.2 Diagnostic Laboratory
8.3.3 Specialty Clinic
8.3.4 Other
Chapter 9: North America Celiac Disease Diagnostics Market Analysis, Insights and Forecast, 2026-2035
9.1 Key Market Trends, Growth Factors and Opportunities
9.2 Impact of Covid-19
9.3 Key Players
9.4 Key Market Trends, Growth Factors and Opportunities
9.4 Historic and Forecasted Market Size By Type
9.4.1 Serology Rapid Test Kit
9.4.2 Gene Rapid Detection Kit
9.5 Historic and Forecasted Market Size By Application
9.5.1 Hospital
9.5.2 Diagnostic Laboratory
9.5.3 Specialty Clinic
9.5.4 Other
9.6 Historic and Forecast Market Size by Country
9.6.1 US
9.6.2 Canada
9.6.3 Mexico
Chapter 10: Eastern Europe Celiac Disease Diagnostics Market Analysis, Insights and Forecast, 2026-2035
10.1 Key Market Trends, Growth Factors and Opportunities
10.2 Impact of Covid-19
10.3 Key Players
10.4 Key Market Trends, Growth Factors and Opportunities
10.4 Historic and Forecasted Market Size By Type
10.4.1 Serology Rapid Test Kit
10.4.2 Gene Rapid Detection Kit
10.5 Historic and Forecasted Market Size By Application
10.5.1 Hospital
10.5.2 Diagnostic Laboratory
10.5.3 Specialty Clinic
10.5.4 Other
10.6 Historic and Forecast Market Size by Country
10.6.1 Bulgaria
10.6.2 The Czech Republic
10.6.3 Hungary
10.6.4 Poland
10.6.5 Romania
10.6.6 Rest of Eastern Europe
Chapter 11: Western Europe Celiac Disease Diagnostics Market Analysis, Insights and Forecast, 2026-2035
11.1 Key Market Trends, Growth Factors and Opportunities
11.2 Impact of Covid-19
11.3 Key Players
11.4 Key Market Trends, Growth Factors and Opportunities
11.4 Historic and Forecasted Market Size By Type
11.4.1 Serology Rapid Test Kit
11.4.2 Gene Rapid Detection Kit
11.5 Historic and Forecasted Market Size By Application
11.5.1 Hospital
11.5.2 Diagnostic Laboratory
11.5.3 Specialty Clinic
11.5.4 Other
11.6 Historic and Forecast Market Size by Country
11.6.1 Germany
11.6.2 UK
11.6.3 France
11.6.4 Netherlands
11.6.5 Italy
11.6.6 Russia
11.6.7 Spain
11.6.8 Rest of Western Europe
Chapter 12: Asia Pacific Celiac Disease Diagnostics Market Analysis, Insights and Forecast, 2026-2035
12.1 Key Market Trends, Growth Factors and Opportunities
12.2 Impact of Covid-19
12.3 Key Players
12.4 Key Market Trends, Growth Factors and Opportunities
12.4 Historic and Forecasted Market Size By Type
12.4.1 Serology Rapid Test Kit
12.4.2 Gene Rapid Detection Kit
12.5 Historic and Forecasted Market Size By Application
12.5.1 Hospital
12.5.2 Diagnostic Laboratory
12.5.3 Specialty Clinic
12.5.4 Other
12.6 Historic and Forecast Market Size by Country
12.6.1 China
12.6.2 India
12.6.3 Japan
12.6.4 South Korea
12.6.5 Malaysia
12.6.6 Thailand
12.6.7 Vietnam
12.6.8 The Philippines
12.6.9 Australia
12.6.10 New Zealand
12.6.11 Rest of APAC
Chapter 13: Middle East & Africa Celiac Disease Diagnostics Market Analysis, Insights and Forecast, 2026-2035
13.1 Key Market Trends, Growth Factors and Opportunities
13.2 Impact of Covid-19
13.3 Key Players
13.4 Key Market Trends, Growth Factors and Opportunities
13.4 Historic and Forecasted Market Size By Type
13.4.1 Serology Rapid Test Kit
13.4.2 Gene Rapid Detection Kit
13.5 Historic and Forecasted Market Size By Application
13.5.1 Hospital
13.5.2 Diagnostic Laboratory
13.5.3 Specialty Clinic
13.5.4 Other
13.6 Historic and Forecast Market Size by Country
13.6.1 Turkey
13.6.2 Bahrain
13.6.3 Kuwait
13.6.4 Saudi Arabia
13.6.5 Qatar
13.6.6 UAE
13.6.7 Israel
13.6.8 South Africa
Chapter 14: South America Celiac Disease Diagnostics Market Analysis, Insights and Forecast, 2026-2035
14.1 Key Market Trends, Growth Factors and Opportunities
14.2 Impact of Covid-19
14.3 Key Players
14.4 Key Market Trends, Growth Factors and Opportunities
14.4 Historic and Forecasted Market Size By Type
14.4.1 Serology Rapid Test Kit
14.4.2 Gene Rapid Detection Kit
14.5 Historic and Forecasted Market Size By Application
14.5.1 Hospital
14.5.2 Diagnostic Laboratory
14.5.3 Specialty Clinic
14.5.4 Other
14.6 Historic and Forecast Market Size by Country
14.6.1 Brazil
14.6.2 Argentina
14.6.3 Rest of SA
Chapter 15 Investment Analysis
Chapter 16 Analyst Viewpoint and Conclusion
Celiac Disease Diagnostics Scope:
|
Report Data
|
Celiac Disease Diagnostics Market
|
|
Celiac Disease Diagnostics Market Size in 2025
|
USD XX million
|
|
Celiac Disease Diagnostics CAGR 2025 - 2032
|
XX%
|
|
Celiac Disease Diagnostics Base Year
|
2024
|
|
Celiac Disease Diagnostics Forecast Data
|
2025 - 2032
|
|
Segments Covered
|
By Type, By Application, And by Regions
|
|
Regional Scope
|
North America, Europe, Asia Pacific, Latin America, and Middle East & Africa
|
|
Key Companies Profiled
|
Thermo Fisher Scientific Inc., PRIMA Lab SA, Glutenostics, Inc., NanoRepro AG., Targeted Genomics, YORKTEST Laboratories, Biohit Oyj, Labsystems Diagnostics Oy, RxHome Test, Biomerica, AESKU.GROUP GmbH, LaCAR MDx Technologies, J. Mitra & Co.Pvt.Ltd., lmaware, Vitrosens Biotechnology.
|
|
Key Segments
|
By Type
Serology Rapid Test Kit
Gene Rapid Detection Kit
By Applications
Hospital
Diagnostic Laboratory
Specialty Clinic
Other
|
